Please ensure Javascript is enabled for purposes of website accessibility

Monsanto Ready to Round Up Growth

By Brian Orelli, PhD - Updated Apr 5, 2017 at 8:04PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's hidden under the dirt for now, but it'll soon start sprouting.

Monsanto (NYSE:MON) won't be selling its Roundup Ready 2 Yield soybean seeds in Europe, but at least the U.S farmers to which it sells will be able to hock their final product there. The company announced yesterday that the European Union had approved the genetically modified soybeans for import.

The E.U. buys about 10% of U.S. soybean exports, so the lack of an approval could have hampered the launch of the Roundup Ready 2 Yield soybeans, which are now approved for import in 10 countries or regions. Monsanto expects to make a small launch next year, with a much larger push the year after.

2010 may seem like a long way off for investors, but that's the way Fools should be thinking. Seed producers, like Monsanto and Syngenta (NYSE:SYT), and fertilizer producers -- such as Mosaic (NYSE:MOS), Agrium (NYSE:AGU), and PotashCorp (NYSE:POT) -- have been punished hard this year. But it's not like people will stop eating just because there's a global recession. And the recession will end -- eventually.

Investors who buy agricultural companies at these levels could see further dips -- the bottom is hard to predict, after all -- but the overall prospects of the agricultural industry are pretty strong. Monsanto is looking to double yields by 2030. With each small increase in yield, like the Roundup Ready 2 Yield products, comes the ability to increase prices. And of course, the Roundup Ready products end up boosting sales twice over -- once for the seed, and another for sales of Monsanto's Roundup herbicide.

Monsanto will grow again. Investors just need to have a little patience.

Rule Breakers is always on the hunt for hot drug stocks and other cutting-edge picks. See all of our latest discoveries with a free 30-day trial subscription.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Monsanto Company Stock Quote
Monsanto Company
Nutrien Stock Quote
The Mosaic Company Stock Quote
The Mosaic Company
$54.39 (0.70%) $0.38

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/10/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.